2021-01-11,IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
2021-01-05,"IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor"
2021-01-04,IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences
2020-12-14,IDEAYA Biosciences Announces Addition to NASDAQ Biotechnology Index
2020-12-11,Is IDYA A Good Stock To Buy Now?
2020-12-08,IDEAYA Biosciences (IDYA) Jumps: Stock Rises 8.2%
2020-11-16,"Industry Analysts Just Upgraded Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts By 95%"
2020-11-15,"Results: IDEAYA Biosciences, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts"
2020-11-12,"IDEAYA Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update"
2020-11-02,IDEAYA to Participate in Upcoming November 2020 Investor Relations Events
2020-10-22,IDEAYA Announces Partnership With The Broad Institute And Advancement Of Synthetic Lethality Programs And Platform
2020-09-24,"The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO"
2020-09-24,IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
2020-09-04,Billionaire Ken Griffin Snaps Up These 3 Strong Buy Stocks
2020-09-02,LD Micro 360 Companies --Set to Present this Week.
2020-08-31,IDEAYA to Participate in Upcoming September 2020 Investor Relations Events
2020-08-19,"What Kind Of Shareholders Hold The Majority In IDEAYA Biosciences, Inc.'s (NASDAQ:IDYA) Shares?"
2020-08-12,"IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates"
2020-08-12,"IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update"
2020-08-07,Is a Surprise Coming for IDEAYA Biosciences (IDYA) This Earnings Season?
2020-08-05,LD Micro--Announces Preliminary List of Presenters for the LD-500.
2020-08-04,IDEAYA Announces HSR Clearance of GSK Strategic Partnership in Synthetic Lethality and Closing of Glaxo Group Equity Investment
2020-07-16,IDEAYA Announces IDE196 Program Update and Clinical Protocol Criteria Met for Cohort Expansion in Skin Melanoma for Phase 2 GNAQ/11 Basket Trial
2020-07-14,"IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020"
2020-07-09,"IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor"
2020-06-30,"IDEAYA Appoints Garret Hampton, Ph.D., to the Board of Directors, an Industry Leader in Precision Medicine Oncology and Diagnostics"
2020-06-22,Repare and Forma Shares Gobbled Up in IPO
2020-06-17,IDEAYA Announces Pricing of Public Offering of Common Stock
2020-06-17,"Biotech Stock Roundup: REGN Begins Coronavirus Study, VRTX, BIIB Give Updates"
2020-06-16,IDEAYA Announces Proposed Public Offering of Common Stock
2020-06-16,P/E Ratio Insights for IDEAYA Biosciences
2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO"
2020-06-16,"IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology"
2020-06-12,"Here is What Hedge Funds Think About IDEAYA Biosciences, Inc. (IDYA)"
2020-06-11,IDEAYA Biosciences Selected to Join Russell 3000Â® Index
2020-06-09,IDEAYA (IDYA) Looks Good: Stock Adds 10.2% in Session
2020-06-08,"IDEAYA Announces Nomination of Development Candidate, IDE397, for MAT2A Synthetic Lethality Program Targeting MTAP-Deletion Patient Population"
2020-05-24,3 Strong Buy Healthcare Stocks That Could Double in the Next Year
2020-05-19,"IDEAYA Biosciences to Participate in Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020"
2020-05-15,IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program
2020-05-12,"IDEAYA Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update"
2020-04-21,"IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team"
2020-03-24,"IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update"
2020-03-18,IDEAYA Biosciences Announces IDE196 Monotherapy Phase 2 Dose Selection and Clinical Program Update
2020-03-18,IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
2020-03-11,"IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities"
2020-02-19,We Think IDEAYA Biosciences (NASDAQ:IDYA) Can Afford To Drive Business Growth
2020-01-15,IDEAYA Biosciences Announces Synthetic Lethality Research Highlights and Target Milestones for 2020
2020-01-10,IDEAYA Biosciences and Boston Children's Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome -  a Rare Disease Associated with Genetic Mutation of GNAQ
2020-01-06,"IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020"
2019-12-26,These new Bay Area stocks from 2019 are 'underwater' as year ends
2019-12-19,"Heres What Hedge Funds Think About IDEAYA Biosciences, Inc. (IDYA)"
2019-12-18,IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors
2019-12-16,IDEAYA Biosciences Sees Hammer Chart Pattern: Time to Buy?
2019-12-09,IDE196 Program Updates: Targeting Initiation of Potentially Registration-Enabling Phase 2 Single-Arm Monotherapy Trial in MUM and Introduction of Tablet Formulation in Q1 2020
2019-11-25,"IDEAYA Biosciences, Inc. (IDYA) Shares March Higher, Can It Continue?"
2019-11-20,Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress
2019-11-15,Phase 1/2 Clinical Trial Progress for IDE196 to be Presented at Society for Melanoma Research Congress
2019-11-13,"IDEAYA Biosciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update"
2019-11-05,IDEAYA Biosciences Announces Leadership Updates in Research Organization
2019-11-01,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance"
2019-10-31,IDEAYA Biosciences Reports EndofPhase 1 Meeting with FDA for IDE196 Confirms Acceptability of Single-Arm Trial Design for Potential Phase 2 Registration-Enabling Study in Metastatic Uveal Melanoma
2019-10-25,IDEAYA Biosciences to Present at Upcoming Investor Conferences
2019-08-23,"How Much Of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Do Institutions Own?"
2019-08-12,"IDEAYA Biosciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update"
2019-07-09,How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs
2019-07-09,"IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone, J.D., as Chief Financial Officer, Andres Ruiz Briseno, C.P.A., as Vice President, Finance, and Mick O'Quigley, M.B.A, as Vice President, Development Operations"
2019-07-01,"Here are big Bay Area winners, losers from busy first half of IPOs"
2019-06-17,"Health Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and more"
2019-05-28,IDEAYA Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
2019-05-23,"Ideaya Biosciences' stock opened 40% above its IPO price, then pared most of its gains"
2019-05-22,IDEAYA Announces Pricing of Initial Public Offering
